"Bloomberg Markets" is focused on bringing you the most important global business and breaking markets news and information as it happens.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human? Reading time 3 ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

To “cure all diseases” someday, Isomorphic Labs is ready to begin human trials of its AI-designed drugs. Artificial intelligence has a terrible reputation among the general public for many reasons, ...

In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Until now, cells dividing by mitosis were thought to grow round and then split into two identical, spherical daughter cells. New research has found that some cells are isomorphic, meaning they retain ...

On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck. Google was investing in his startup. The ...

Stream NBC 5 for free, 24/7, wherever you are. On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck.

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

London-based Isomorphic Labs, an AI-focused drug design and development company, has raised $600M (nearly €555.44M) in its first external funding round. The round is led by Thrive Capital, with ...

Turns out AI can be used for more than Ghibli-ifying selfies. AI drug developer Isomorphic Labs raised $600 million in its first external funding round as hype builds around AI-powered biotech.